Clinical Evidence: What the Weight Loss Trials Show
Understanding Mounjaro vs Wegovy Weight Loss Mechanisms
When comparing Mounjaro vs Wegovy for weight loss, the fundamental difference lies in their mechanisms of action. Wegovy (semaglutide) works as a GLP-1 receptor agonist, mimicking a natural hormone that signals fullness to the brain and slows gastric emptying. Mounjaro (tirzepatide) takes a dual approach, targeting both GIP and GLP-1 receptors, which may explain its enhanced effectiveness in clinical trials. Both treatments are prescription-only medicines that must be used alongside a reduced-calorie diet and increased physical activity. The dual receptor targeting of Mounjaro represents a newer approach to weight management, while Wegovy's established GLP-1 pathway has extensive long-term safety data.
Your choice between these treatments will depend on various factors including your medical history, weight loss goals, and practical considerations like storage requirements. Both medications require weekly injections using pre-filled pens, with gradual dose escalation to minimise side effects. The decision between Mounjaro vs Wegovy for weight loss should always be made in consultation with a qualified prescriber who can assess your individual circumstances. At EverydayMeds (GPhC #9012878), our clinical team provides expert guidance to help determine the most suitable treatment approach for your weight management journey.
Wegovy Pricing and Value at EverydayMeds
Understanding the cost comparison between Mounjaro vs Wegovy for weight loss helps inform your treatment decision. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose (£209.99). Our bundle options provide convenience for your weight loss journey, including the Intro Trio covering your first three months (0.25mg, 0.5mg & 1mg) for £299.99. New customers can apply code FIRST40 at checkout, while returning customers use DOSE25, with these discount codes already factored into our competitive pricing structure.
Comparing value goes beyond initial cost when evaluating Mounjaro vs Wegovy for weight loss. Wegovy's established track record includes comprehensive long-term safety data and proven cardiovascular benefits from the SELECT trial. The convenience of longer room temperature storage (6 weeks vs Mounjaro's 21 days) adds practical value for travel and daily management. Our Ultimate Stability Trio provides three months of maintenance 2.4mg supply for £649.99, ensuring consistent treatment without frequent reordering. Both treatments require similar commitment to lifestyle changes, making the choice between Mounjaro vs Wegovy for weight loss a decision based on individual medical factors rather than cost alone.
Clinical Trial Evidence for Weight Loss Results
The STEP trial programme provides robust evidence for Wegovy's effectiveness in weight management. In STEP 1, participants taking Wegovy alongside lifestyle interventions achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 3 demonstrated enhanced results of ~16% when combined with intensive behavioural therapy, while STEP 5 showed sustained weight loss of ~15.2% maintained over two years.
When comparing Mounjaro vs Wegovy for weight loss through clinical evidence, Mounjaro's SURMOUNT-1 trial showed approximately 22.5% average weight loss with the highest dose. However, direct comparison requires caution as trials used different populations, endpoints, and study designs. The SELECT trial uniquely demonstrated Wegovy's cardiovascular benefits, showing a 20% reduction in major cardiovascular events. Both treatments have shown superior results compared to placebo when combined with lifestyle modifications, emphasising that medication forms part of a comprehensive weight management approach rather than a standalone solution.
How Wegovy Works for Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of incretin hormones naturally produced in your intestines after eating. This mechanism helps reduce appetite by signalling satiety to brain centres that control hunger, while simultaneously slowing gastric emptying to maintain feeling full for longer periods. The medication may also reduce food cravings by influencing reward pathways in the brain associated with food-seeking behaviour. Unlike appetite suppressants that work through stimulant mechanisms, Wegovy's approach aligns with natural physiological processes that regulate energy balance. This mechanism requires consistent weekly dosing to maintain therapeutic levels, with effects typically becoming noticeable within the first few weeks of treatment. The gradual dose escalation protocol helps your body adapt to these metabolic changes while minimising potential gastrointestinal side effects.
EverydayMeds Ordering Process
Starting your weight loss journey with either treatment through EverydayMeds involves a streamlined three-step process designed for convenience and safety. The initial online clinical assessment takes approximately three minutes, covering your medical history, current medications, and weight loss goals to ensure treatment suitability. Our registered prescribers review your assessment within three working days (express 24-hour service available), ensuring thorough evaluation before approving your prescription. Once approved, your medication ships via next-day delivery using temperature-controlled cold-chain packaging to maintain product integrity. The entire process maintains full compliance with MHRA regulations and NICE guidelines, ensuring you receive genuine medication with proper clinical oversight. Our ongoing support includes dosing guidance, side effect management, and prescription renewals to support your long-term weight management success.
Storage and Practical Considerations
Storage requirements present a practical advantage when comparing Mounjaro vs Wegovy for weight loss, particularly for active lifestyles or frequent travel. Wegovy maintains stability for up to six weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. Both medications require refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature stability offers greater flexibility for holidays, business trips, or emergency situations. The FlexTouch pen system used by Wegovy provides intuitive dosing with clear dose confirmation, while both treatments follow similar weekly injection schedules. Proper storage ensures medication potency throughout your treatment, making these practical considerations important factors in your decision between Mounjaro vs Wegovy for weight loss. The dose escalation schedule requires planning ahead to ensure continuous supply, with our bundle options designed to simplify this process.
UK-Specific Weight Loss Results and NICE Guidance
UK weight loss results for both treatments align with international clinical trial data, but NICE guidance specifically recommends Wegovy (TA875) within specialist weight management programmes. The NHS evaluation process considers both clinical effectiveness and cost-effectiveness when comparing treatments like Mounjaro vs Wegovy for weight loss. Real-world UK data continues to support clinical trial findings, with patients achieving significant weight loss when treatments are combined with appropriate lifestyle interventions.
EverydayMeds operates under full MHRA licensing and GPhC registration (#9012878), ensuring UK patients receive authentic medications with proper clinical oversight. The additional monitoring status (Black Triangle ▼) applied to Wegovy reflects its relatively recent approval rather than safety concerns, with ongoing surveillance maintaining high safety standards. UK prescribers have access to comprehensive safety data spanning multiple years of use, informing evidence-based decisions when comparing Mounjaro vs Wegovy for weight loss options for individual patients.
Making Your Treatment Choice
The decision between Mounjaro vs Wegovy for weight loss ultimately depends on individual medical factors, lifestyle considerations, and prescriber guidance rather than a universal "best" option. Both treatments have demonstrated significant effectiveness in clinical trials, with the choice often coming down to factors like storage requirements, dosing schedule preferences, and your medical history. EverydayMeds provides both options with identical high standards of clinical oversight, cold-chain delivery, and ongoing support throughout your weight management journey. Our registered prescribers can help evaluate which treatment aligns best with your specific circumstances and goals. Remember to use code FIRST40 for new customers or DOSE25 for returning customers at checkout, and begin your assessment at https://everydaymeds.co.uk/collections/wegovy to explore your options. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which is right for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
